0000950170-24-001141.txt : 20240103
0000950170-24-001141.hdr.sgml : 20240103
20240103172152
ACCESSION NUMBER: 0000950170-24-001141
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240101
FILED AS OF DATE: 20240103
DATE AS OF CHANGE: 20240103
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kling Douglas F
CENTRAL INDEX KEY: 0001699022
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41562
FILM NUMBER: 24508219
MAIL ADDRESS:
STREET 1: C/O MATINAS BIOPHARMA HOLDINGS, INC.
STREET 2: 1545 ROUTE 206 SOUTH, SUITE 302
CITY: BEDMINSTER
STATE: NJ
ZIP: 07921
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NewAmsterdam Pharma Co N.V.
CENTRAL INDEX KEY: 0001936258
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: P7
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: GOOIMEER 2-35
CITY: NARRDEN
STATE: P7
ZIP: 1411 DC
BUSINESS PHONE: 35 206 2971
MAIL ADDRESS:
STREET 1: GOOIMEER 2-35
CITY: NARRDEN
STATE: P7
ZIP: 1411 DC
FORMER COMPANY:
FORMER CONFORMED NAME: NewAmsterdam Pharma Co B.V.
DATE OF NAME CHANGE: 20220701
4
1
ownership.xml
4
X0508
4
2024-01-01
0001936258
NewAmsterdam Pharma Co N.V.
NAMS
0001699022
Kling Douglas F
C/O NEWAMSTERDAM PHARMA COMPANY N.V.
GOOIMEER 2-35
NAARDEN
P7
1411 DC
NETHERLANDS
false
true
false
false
Chief Operating Officer
false
Option (right to buy)
11.17
2024-01-01
4
A
false
323771
0.00
A
2034-01-01
Ordinary Shares
323771
323771
D
25% of the shares underlying the option will vest on January 1, 2025, the one-year anniversary of vesting start date, with the remaining shares vesting in equal monthly installments thereafter for three years, subject to the Reporting Person's continued service through each such date.
/s/ Louise Kooij by Power of Attorney from Douglas F. Kling
2024-01-03